Endometrial Cancer and Tamoxifen

This publication has 13 references indexed in Scilit:

• From Adjuvant Therapy to Breast Cancer Prevention: BCPT and STAR
  The Breast Journal, 2001
• Contemporary issues in the management of endometrial cancer.
  CA: A Cancer Journal for Clinicians, 1998
• Tamoxifen and the endometrium: findings of pelvic ultrasound examination
  Breast Cancer Research and Treatment, 1998
• Different Coexisting Endometrial Histological Features in Asymptomatic Postmenopausal Breast Cancer Patients Treated with Tamoxifen
  Gynecologic and Obstetric Investigation, 1997
• Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study
  Ultrasound in Obstetrics & Gynecology, 1995
• Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen‐treated women with breast cancer: a transvaginal Doppler study
  Ultrasound in Obstetrics & Gynecology, 1995
• Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features
  Gynecologic Oncology, 1994
• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• Endometrial Sampling: When? Where? Why? With What?
  Clinical Obstetrics and Gynecology, 1992
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989